Reverse DCF
What growth does the market imply for MEDICO?
Working backwards from the current price to find the FCF growth assumption baked in.
unrealistic
43.1% implied annual FCF growth
The market is pricing in hyper-growth that virtually no established company has sustained for 10 years. This implies either a structural disruption scenario or significant overvaluation.
Current Price
₹43
Historical Growth
20.0%
FCF Yield
0.38%
Price / FCF
259.8x
Plain English
To justify today's price of ₹43.34, MEDICO.NS needs to grow its free cash flow at 43.1% per year for the next 10 years. That is 23.1% faster than its historical growth rate of 20.0%. At its historical growth rate, the stock cannot justify its current price within a 20-year horizon. The market is pricing in a step-change in performance.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| GDP rate | 10.0% | ₹2 | -95.9% |
| Historical | 20.0% | ₹6 | -85.5% |
| Half implied | 21.6% | ₹7 | -83.1% |
| Implied | 43.1% | ₹43 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At 20.0% growth, the model values MEDICO at ₹6, below today's ₹43.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.